Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?

PURPOSE: Radical cystectomy (RC) is the standard treatment for high-risk non muscle-invasive bladder cancer (NMIBC) failing first BCG treatment. A second BCG course is an option for those patients who refuse RC or are not eligible for it, but its success rate is quite low. Aim of the present study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Busetto, Gian Maria, Finati, Marco, Chirico, Marco, Cinelli, Francesco, D’Altilia, Nicola, Falagario, Ugo G., Sanguedolce, Francesca, Del Giudice, Francesco, De Berardinis, Ettore, Ferro, Matteo, Crocetto, Felice, Porreca, Angelo, Di Gianfrancesco, Luca, Calo’, Beppe, Mancini, Vito, Bettocchi, Carlo, Carrieri, Giuseppe, Cormio, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188396/
https://www.ncbi.nlm.nih.gov/pubmed/36971825
http://dx.doi.org/10.1007/s00345-023-04372-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188396/
https://www.ncbi.nlm.nih.gov/pubmed/36971825
http://dx.doi.org/10.1007/s00345-023-04372-5

Ejemplares similares